Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resonance Health Ltd RHT


Primary Symbol: RSHTF

Technology Scientific & Technical Instruments
Resonance Health Limited is an Australia-based healthcare technology and services company engaged in the development and commercialization of software-as-medical-device (SaMD) technologies and services for the quantitative analysis of radiological images in a regulated and quality-controlled environment. Its portfolio includes Core Lab and artificial intelligence (AI)-powered products to partner with clinicians and radiologists for diagnosis, and management of patients. Its core SaMD product is FerriScan, a non-invasive liver analysis technology used for the assessment of iron in the liver. Its other SaMDs include Cardiac T2, for the assessment of iron in the heart, and HepaFat-Scan for the assessment of fat in and around the liver. It also has several AI-assisted SaMDs, including FerriSmart, HepaFat-AI, and LiverSmart. It operates as the Clinical Trial Research Organisation (CRO) and local sponsor for a major global pharma company's clinical trial in Australia of a new drug compound.


OTCPK:RSHTF - Post by User

Resonance Health Ltd
<< Previous
 Bullboard Posts
User Avatar Image
(0)
•••
Post by SwingTrader149on Feb 16, 2019 6:27pm
133 Views
Post# 29375988

Buffett gets in bed with RHT

Buffett gets in bed with RHTSeems to me like this is the strongest signal that this deal closes....

$750m bet for $45m in profit if the deal closes.

Anyone else surpised that Berkshire jumped into the M&A business?
<< Previous
 Bullboard Posts
Dealroom for high-potential pre-IPO opportunities